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Surveillance in Switzerland
Stefan P. Kuster, MD, MSc;1,2,a Marie-Christine Eisenring, CNS, ICP;1,3,a Hugo Sax, MD;1,2
Nicolas Troillet, MD, MSc;1,3,4 Swissnosob
objective. To assess the structure and quality of surveillance activities and to validate outcome detection in the Swiss national surgical site
infection (SSI) surveillance program.
design. Countrywide survey of SSI surveillance quality.
setting. 147 hospitals or hospital units with surgical activities in Switzerland.
methods. Site visits were conducted with on-site structured interviews and review of a random sample of 15 patient records per hospital: 10 from
the entire data set and 5 from a subset of patients with originally reported infection. Process and structure were rated in 9 domains with a weighted
overall validation score, and sensitivity, speciﬁcity, positive predictive value, and negative predictive value were calculated for the identiﬁcation of SSI.
results. Of 50 possible points, the median validation score was 35.5 (range, 16.25–48.5). Public hospitals (P< .001), hospitals in the Italian-
speaking region of Switzerland (P= .021), and hospitals with longer participation in the surveillance (P= .018) had higher scores than others.
Domains that contributed most to lower scores were quality of chart review and quality of data extraction. Of 49 infections, 15 (30.6%) had been
overlooked in a random sample of 1,110 patient records, accounting for a sensitivity of 69.4% (95% conﬁdence interval [CI], 54.6%–81.7%), a
speciﬁcity of 99.9% (95% CI, 99.5%–100%), a positive predictive value of 97.1% (95% CI, 85.1%–99.9%), and a negative predictive value of
98.6% (95% CI, 97.7%–99.2%).
conclusions. Irrespective of a well-deﬁned surveillance methodology, there is a wide variation of SSI surveillance quality. The quality of
chart review and the accuracy of data collection are the main areas for improvement.
Infect Control Hosp Epidemiol 2017;38:1172–1181
Surgical site infections (SSIs) are the most common
hospital-acquired infections; they are associated with increased
morbidity and mortality, prolonged length of hospital stay, and
increased cost.1–6 Infection surveillance with feedback has been
shown to reduce SSI rates.7 Nationwide SSI surveillance has been
performed in Switzerland since 2011.8 In line with a broader
international trend, SSI rates of each participating hospital have
been made publicly available since 2014, reinforcing the need for
valid data collection.
Surveillance methods should be standardized to ensure the
quality and reliability of surveillance data.9 The accuracy of the
data depends on the experience, qualiﬁcations, training, and
awareness of the surveillance staff.10,11 Validation is the only
independent means to determine the accuracy of surveillance
data; thus, validation is essential in determining the reliability
of a SSI surveillance network in which data are aggregated
from multiple data collectors and are used for comparisons
among hospitals.12,13
Validation measures are designed to detect potential sources of
bias. With regard to validation of SSI surveillance, particularly
selection bias (methods of patient inclusion), information and
detection bias (completion of required medical information), and
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assessment bias (correct interpretation of the study outcome)
need to be considered. Although the best means of validating
a SSI surveillance module is still unknown, methods of calculating
sensitivity, speciﬁcity, positive predictive values, and negative
predictive values (with or without structured interviews
for structure and process validation) have been widely
acknowledged.14–18
To assess the quality of the Swissnoso SSI surveillance program,
structure and process for SSI surveillance were reviewed at all
participating hospitals using audits and structured interviews
with all persons involved in surveillance. SSI outcome data
were validated by reviewing a random sample from each hospital
of 10 patient records (with or without infection) and 5 additional
randomly selected records of patients with infection.
materials and methods
SSI Surveillance Method
In Switzerland, the ﬁrst multicenter surveillance system for SSI
was developed in the mid-1990s. The system was developed
according to the principles of the US National Nosocomial
Infections Surveillance (NNIS) system, currently known as
the National Healthcare Safety Network (NHSN)19–23 and is
described in detail in a previous publication.8 Full documentation
of the surveillance methodology is available for participating
hospitals on the Swissnoso website.14
Since 2014, starting with the 2011 data, when participation in
the program became mandatory, the Swiss National Association
for the Development of Quality in Hospitals and Clinics (ANQ)
has openly publishing the surveillance results by hospital,
including their names, NNIS/NHSN-adjusted SSI rates, and
quality of surveillance as rated during onsite visits.24
Validation of Participating Hospitals
Since October 1, 2012, we validated the structure and process
of SSI surveillance as well as SSI outcome data during dedi-
cated validation visits for all hospitals required to participate in
the program nationwide using a standardized data collection
form. Hospitals were visited on site by 1 of 3 speciﬁcally
trained investigators (2 registered nurses and 1 physician) with
profound knowledge of the Swissnoso SSI surveillance
methodology.
Surveillance Structure and Process Assessment
On-site structured interviews and observations of the surveillance
process were performed with all persons involved in SSI surveil-
lance, regardless of education, background, or the percentage of
full-time equivalents ascribed for surveillance.
A weighted score was attributed according to a structured that
was developed based on existing literature and expert consensus.
The questionnaire covered training of persons performing the
surveillance, work environment (including understafﬁng),
potential conﬂicts of interest, data sources for patient selection,
completeness of inclusion, completeness of required medical
information (for diagnosis of SSI, during hospitalization and after
discharge), quality of postdischarge surveillance, presence and
type of medical supervision, and losses to follow-up (ie, attrition
bias) (Table 1 and Supplemental Tables S1, S2, and S3). When
different teams performed SSI surveillance at different sites or
units of a hospital (eg, pediatric surgery, abdominal surgery, or
cardiac surgery), each team was assessed separately and a score
was attributed to each team.
SSI Outcome Validation
Patient records of electronic case report forms (eCRFs) submitted
between January 1, 2009, and October 31, 2015, were eligible for
review. A random sample of 10 patient records was drawn from
all cases and all types of surgeries that were submitted by each
respective hospital, irrespective of the presence or absence of SSI
(Dataset A). In addition, for each hospital, 5 records of patients
with SSI were randomly selected from all cases and all types of
surgeries with originally reported infections that were submitted
by the respective hospital (Dataset B).
Patient records were reviewed by the validators with assis-
tance from on-site participants and were checked against
eCRFs and paper CRFs. The outcome determination by the
independent investigator was regarded as the gold standard.
All cases with infection, all misclassiﬁcations (false positive and
false negative), and all questionable cases needing further
clariﬁcation were reviewed and resolved by consensus with 1
or 2 additional senior investigators (M.C.E. and N.T.).
Statistical Analysis
Descriptive statistics were used to outline the surveillance struc-
tures and processes of participating hospitals. Differences
between groups were assessed in univariate analyses using the χ2,
Fisher’s exact test, Wilcoxon rank-sum test, or Student t test, as
appropriate. Multivariate linear regression analysis was used to
evaluate associations between surveillance parameters (ie, lan-
guage region, hospital size, hospital status [private vs public],
number of hospital beds, full-time equivalents dedicated to sur-
veillance, duration of participation in surveillance) and validation
scores for the overall score and scores within individual domains.
Multivariate analyses assessing the association between surveil-
lance structure and process parameters (ie, language region,
hospital size, hospital status [private vs public], number of pro-
cedures included per year, full-time equivalents dedicated to
surveillance, understafﬁng, and overall validation score and
scores of individual domains, respectively), and misclassiﬁcation
of infections status and types of infections, respectively, were
performed using generalized estimating equations (GEE; logit
link models with binomial distribution of the dependent variable
and exchangeable within-group correlation structure). This
method accounted for cluster effects on the hospital level, as
several cases per hospital that shared the same surveillance
structure and process parameters were assessed.
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The quality of outcome reporting dataset comprising all
randomly drawn cases (ie, cases with and without infection, as
classiﬁed by the hospital) from each visited hospital yielded
cases that fell into 4 categories: (1) cases reported by hospital
and identiﬁed by Swissnoso validation staff as SSI cases (true
positives); (2) cases not reported by hospital and ruled out as
SSI cases by Swissnoso validation staff (true negatives);
(3) cases reported by hospital but ruled out as SSI cases by
Swissnoso validation staff (false positives); and (4) cases not
reported by the hospital but identiﬁed as SSI cases by
Swissnoso validation staff (false negatives). From these num-
bers, sensitivity, speciﬁcity, positive predictive value, and
negative predictive value with 95% conﬁdence intervals were
calculated for the overall data set, with the exception of cases
with incomplete information at the time of the validation visit.
All statistical analyses were performed using Stata 14.2
software (StataCorp, College Station, TX), and 2-sided
P values < .05 were considered statistically signiﬁcant.
Sample Size Estimation
In a preceding sample-size estimation, a random sample of 913
patient records was considered necessary to achieve a 95%
conﬁdence interval for sensitivity of 5% when an overall SSI
prevalence of 8% and a sensitivity of 95% were assumed.25
results
Between October 1, 2012, and June 26, 2016, all 147 hospitals or
hospital units that participated in the surveillance and had sub-
mitted cases by October 31, 2015, were visited and audited in 25
of 26 Swiss cantons. Overall, 107 hospitals (72.8%) were from the
German-speaking region of Switzerland; 31 (21.1%) were from
the French-speaking region, and 9 (6.1%) were from the Italian-
speaking region. 96 (65.3%) were public hospitals or hospital
units, and 9 (6.1%) were university afﬁliated. Furthermore,
87 (59.2%) hospitals participated in the surveillance for more
than 3 years at the time of validation (median time of participation:
3.4 years; range, 0.8–15.8 years).
Structure and Process Validation
The characteristics of the 147 surveillance teams are shown in
Table 1. The 2 surgical procedures that are most strongly
represented are colon surgery (followed by 70.8% of validated
hospitals) and hip prosthesis surgery (69.4%). Understafﬁng
was noted in 34.7% of the surveillance teams, and 35.4% of
medical supervisors had not undergone the required struc-
tured training in the surveillance methodology. Conﬂicts of
interest (ie, surveillance supervised by a member of the surgical
team) were detected among 11.6% of medical supervisors.
Table 2 depicts the 9 domains assessed in the process
validation score, their individual scores and weights, and the
unweighted mean score per domain among the 147 hospitals
or hospital units. The overall mean score was 34.85 points
(standard deviation [SD], 6.95 points), with a median of 35.5
points (range, 16.25–48.5 points) for a maximum of 50 points
(Figure 1). The 2 domains that contributed most to lower scores
were ‘follow-up during hospitalization’ (weighted mean differ-
ence from maximum score, 3.97 points; SD, 2.30 points) and
‘data quality of eCRF compared to original data’ (weighted mean
difference from maximum score: 3.22 points; SD, 1.64 points).
The associations between hospital status, language
region, duration of participation in the surveillance program,
and hospital size with scores within individual domains
are depicted in Table 3. In multivariate linear regression
analysis, public hospital status (P< .001), Italian-speaking
region (P= .021) and duration of participation in the
surveillance programs (P= .018) were associated with higher
validation scores, whereas hospital size was not. The number
of full-time equivalents dedicated to surveillance was neither
associated with the overall score nor with scores of individual
domains.
SSI Outcome Validation
A total of 1,110 randomly selected clinical cases (Dataset A, ie,
irrespective of the presence or absence of SSI) with complete
table 1. Surgical Interventions Included in the Validation and
Followed by the147 Audited Surveillance Teams, and Team Characteri-
stics, October 1, 2012, to June 26, 2016
Variable Value
Surgical procedures followed, No. (%)
Appendectomy 62 (42.2)
Colon surgery 104 (70.8)
Rectum surgery 15 (10.2)
Cholecystectomy 49 (33.3)
Herniorrhaphy 49 (33.3)
Gastric bypass surgery 10 (6.8)
Caesarian section 46 (31.3)
Hip prostheses 102 (69.4)
Knee prostheses 66 (44.9)
Cardiac surgery 12 (8.2)
No. of procedures included per year, median (range) 300 (15–2,000)
Full-time equivalents dedicated to surveillance,
median (range)
0.2 (0.01–1.3)
Understafﬁng compared to volume of operations
included, No. (%)
51 (34.7)
Adequate professional background of persons
performing surveillance, No. (%)
134 (91.2)
Specialization of medical supervisor
Internal medicine alone, No. (%) 32 (21.8)
Infectious diseases with or without internal
medicine, No. (%)
84 (57.1)
Surgery, No. (%) 9 (6.1)
Anesthesiology, No. (%) 17 (11.6)
Other, No. (%) 5 (3.4)
Inadequate training of medical supervisor in the
surveillance methodology, No. (%)
52 (35.4)
Conﬂict of interest of medical supervisor, No. (%) 17 (11.6)
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follow-up were reviewed between October 1, 2012, and June 26,
2016. The overall infection rate , as determined by the validators,
was 4.4% (95% conﬁdence interval [CI], 3.3%–5.8%). The
characteristics of these cases are shown in Table 4. Overall,
15 cases (1.4%) were incorrectly classiﬁed as no infection, and
1 case (0.09%) was misclassiﬁed as an infection, accounting for a
speciﬁcity of the surveillance of 99.9% (95% CI, 99.5%–100%),
a sensitivity of 69.4% (95% CI, 54.6%–81.7%), a positive
predictive value of 97.1% (95% CI, 85.1%–99.9%), and
a negative predictive value of 98.6% (95% CI, 97.7%–99.2%).
Of the 15 false negatives, 9 occurred in colon surgery cases, 3 in
hip prosthesis cases, 2 in caesarean section cases, and 1 in an
appendectomy case. 8 of these 15 cases (53.3%) were superﬁcial
incisional infections and 7 (46.7%) were organ-space infections.
The 15 cases with missed infections were from 15 different
hospitals; 4 (26.7%) were missed in private hospitals and
10 (66.7%) were missed in in non–university-afﬁliated public
hospitals. Furthermore, 1 (6.7%) occurred in a university-
afﬁliated hospital, corresponding to the distribution of reviewed
cases among these hospital categories.
In univariate GEE, misclassiﬁcation of infection status was
associated with lower quality of supervision of suspected cases
by a medical supervisor (P= .009), and unweighted mean
(standard deviation) scores in cases with false-negative
table 2. Domains, Scores, Weights, and Mean Scores per Domain in 147 Surveillance Teams
No. Domain Score and Evaluation Weight
Unweighted
Mean Score
(SD)
Weighted
Mean Difference From
Maximum Score (SD)
1 Inclusion of cases 0 points Apparent selection bias 2 2.42 (0.78) 1.17 (1.56)
1 point Selection bias probable
2 points Selection bias possible
3 points Complete, no selection bias
2 Medical documentation 0 points Documentation mostly incomplete 3 1.72 (0.46) 0.83 (1.37)
1 point Documentation partially incomplete
2 points Documentation complete
3 Follow-up during
hospitalization
0 points No review of medical documentation 3 1.68 (0.77) 3.97 (2.30)
1 point Incomplete review or only in case of suspicion
of infection during phone interview
2 points Complete review
3 points Complete review with documentation of
reasoning
4 Postdischarge surveillance,
including phone interview
0 points Not performed 1.5 1.77 (0.97) 1.85 (1.46)
1 point Incomplete
2 points Complete, locally adapted form
3 points Complete, standardized form
5 Data quality of eCRF
compared to original data
0 points ≥6 mistakes 1.5 0.85 (1.09) 3.22 (1.64)
1 points 3–5 mistakes
2 points 2 mistakes
3 points ≤1 mistake
6 Documentation of cases with
infection
0 points None 1.5 1.76 (0.97) 1.86 (1.46)
1 point Incomplete
2 points Complete
3 points Complete and reviewed by medical supervisor
7 Supervision of suspected cases
by medical supervisor
0 points Never 2 2.60 (0.72) 0.81 (1.45)
1 point Occasionally
2 points Regularly
3 points Always
8 Medical supervisor’s
background
0 points None 1.5 2.50 (0.71) 0.75 (1.06)
1 points Surgeon or dedicated nurse alone
2 points Surgeon together with internist
3 points Infectious diseases specialist and/or internist
9 Training 0 points No participation in a training session 2.5 1.72 (0.51) 0.69 (1.29)
1 points Incomplete, not all staff members participating
in surveillance have attended a training session
2 points Complete, all staff members participating in
surveillance have attended a training session
All domains Maximum unweighted score: 25 points 17.02 (3.51) 15.15 (6.95)
NOTE. SD, standard deviation; eCRF, electronic case report form.
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classiﬁcation were 2.1 (0.93) compared to 2.61 (0.72) for cases
without false-negative classiﬁcation (Table 2, Domain 7).
However, misclassiﬁcation of infection status was not asso-
ciated with the overall validation score or other domains of the
score, hospital size, private hospital status, number of opera-
tions followed, medical training of the medical supervisor, or
full-time equivalents dedicated for surveillance or under-
stafﬁng (Supplemental Table S4).
In total, 486 cases with infections were randomly selected from
128 of 147 (87.1%) hospitals or hospital units (Dataset B, ie,
randomly selected cases among those with SSI, as classiﬁed by the
hospitals). The remainder of hospitals had no cases of infection at
the time of the validation visit. Among these 486 cases, 204
(42.2%) were superﬁcial incisional infections, 52 (10.8%) were
deep incisional infections, and 226 (46.8%) were organ-space
infections (Table 5). Misclassiﬁcations occurred in 46 (9.5%)
cases. 11 superﬁcial incisional infections were incorrectly classi-
ﬁed as deep incisional (n= 7) or organ-space (n= 4) infections, 4
deep incisional infections were incorrectly classiﬁed as superﬁcial
incisional infections, and 31 organ-space infections were incor-
rectly classiﬁed as superﬁcial incisional (n= 7) or deep incisional
(n= 24) infections. 9.4% of classiﬁcations were incorrect in colon
surgery, 21.2% in infections after hip arthroplasty and 18.2% in
knee arthroplasty, the latter two mainly due to incorrect classi-
ﬁcation of organ-space infections as deep incisional infections.
These 46 misclassiﬁcations occurred in 34 hospitals or hospital
units. Of 34 hospitals, 8 (23.5%) had 2 cases with misclassi-
ﬁcation, 2 hospitals (5.9%) had 3. In univariate GEE, mis-
classiﬁcation of types of infections was associated with lower
overall validation scores (P< .001), higher number of operations
performed (P= .021), lower adequacy of follow-up during hos-
pitalization (P= .015), lower adequacy of documentation of cases
with infection (P< .001), lower quality of supervision of sus-
pected cases by the medical supervisor (P= .003, domain no. 7;
see Table 2), lower infectious-diseases–related expertise of the
medical supervisor (medical supervisor’s background; P= .007),
and lower participation in mandatory training sessions
(P= .009). In multivariate GEE, misclassiﬁcation was indepen-
dently associated with lower adequacy of documentation of cases
with infection (P= .023) (Supplemental Table S5).
discussion
Using on-site, full-day visits in all hospitals participating in SSI
surveillance in Switzerland, we have demonstrated a wide varia-
tion of surveillance quality, with overall quality scores ranging
from 16.25 to 48.5 (of 50) points. Room for improvement was
detected for the important domains of chart review and quality of
data extraction from patient charts. Overall, 15 infections were
not reported, accounting for 1.4% of all cases that were classiﬁed
as no SSIs by the hospitals and 30.6% of all included SSIs.
The association between Italian-speaking region and the overall
score was possibly associated with the involvement of the same
study personnel in the surveillance across several hospitals, guar-
anteeing better homogeneity in surveillance methodology. Public
hospitals perform more extensive medical documentation to
ensure high treatment quality across different treatment teams and
thus reached higher validation scores. In private hospitals, there
may be less variation inmedical personnel involved in patient care;
thus, thorough documentation may not be considered equally
important. Last, the expertise that accumulates over the years
explains the association between overall validation scores and
duration of participation in the surveillance program. Our dataset
showed an association between misclassiﬁcations of infection
ﬁgure 1. Distribution of scores in 147 participating surveillance teams audited between October 1, 2012, and June 26, 2016.
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table 3. Factors Associated With Higher Scores Within Individual Domains in 147 Surveillance Teams
Domaina
Factor
Inclusion
of Cases,
P Value
Medical
Documenta-
tion, P Value
Follow-up
During
Hospitaliza-
tion, P Value
Post-Discharge
Surveillance,
Including Phone
Interview,
P Value
Data Quality of
eCRF Compared
to Original data,
P Value
Documentation
of Cases With
Infection,
P Value
Supervision of
Suspected Cases
by Medical
Supervisor,
P Value
Medical
Supervisors
Background,
P Value
Training,
P Value
Overall
Score (All
Domains),
P Value
Univariate models
Language region
German Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
French .25 .005 .26 .62 .16 .38 .42 .001 .46 .77
Italian .05 .25 .019 .58 .42 .014 .85 .361 .28 .016
Public hospital status .016 <.001 .55 .68 .49 .001 .037 <.001 <.001 <.001
No. of hospital beds .004 .12 .10 .51 .36 .001 .42 .001 .07 .004
Duration of
participation in
surveillance
.001 .012 <.001 .96 .93 .001 .22 .011 .015 <.001
FTE dedicated for
surveillance
.72 .53 .50 .15 .89 .07 .13 .86 .28 .67
Multivariate model
Language region
German Ref Ref. Ref. Ref. Ref. Ref Ref Ref Ref Ref
French .21 .022 .50 .54 .53 .25 .53 <.001 .14 .55
Italian .11 .162 .09 .55 .49 .014 1.00 .15 .19 .021
Public hospital status .38 <.001 .71 .41 .79 .018 .03 <.001 <.001 <.001
No. of hospital beds .07 .31 .33 .41 .46 .042 .06 .10 .87 .41
Duration of
participation in
surveillance
.046 .24 .009 .89 .87 .15 .27 .99 .51 .018
NOTE. ECRF, electronic case report form; FTE, full-time equivalents.
aBold values indicate statistical signiﬁcance in multivariate models.
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table 4. Characteristics of 1,110 Randomly Selected Clinical Cases With Complete Follow-Up Reviewed Between October 1, 2012, and June 26, 2016
Variable Total
True Positive,
No. (%)
True Negative,
No. (%)
False Positive,
No. (%)
False Negative,
No. (%)
PPV, %
(95% CI)
NPV, %
(95% CI)
Sensitivity
(95% CI)
Speciﬁcity
(95% CI)
All surgeries 1,110 34 (3.1) 1,060 (95.4) 1 (0.1) 15 (1.4) 97.1 (85.1–99.9) 98.6 (97.7–99.2) 69.4 (54.6–81.7) 99.9 (99.5–100)
Appendectomy 110 5 (4.6) 104 (94.6) 0 (0) 1 (0.9) 100 (47.8 – 100) 99.0 (94.8–100) 83.3 (35.9–99.6) 100 (96.5–100)
Colon surgery 144 18 (12.5) 116 (80.6) 1 (0.7) 9 (6.3) 94.7 (74.0–99.9) 92.8 (86.8–96.7) 66.7 (46.0–83.5) 99.1 (95.3–100)
Rectum surgery 8 0 (0) 8 (100) 0 (0) 0 (0) NA 100 (63.1–100) NA 100 (63.1–100)
Cholecystectomy 123 3 (2.4) 120 (97.6) 0 (0) 0 (0) 100 (29.2–100) 100 (97.0–100) 100 (29.2–100) 100 (97.0–100)
Herniorrhaphy 165 0 (0) 165 (100) 0 (0) 0 (0) NA 100 (97.8–100) NA 100 (97.8–100)
Gastric bypass surgery 2 0 (0) 2 (100) 0 (0) 0 (0) NA 100 (15.8–100) NA 100 (15.8–100)
Caesarian section 180 2 (1.1) 176 (97.8) 0 (0) 2 (1.1) 100 (15.8–100) 98.9 (96.0–99.9) 50.0 (6.8–93.2) 100 (97.9 – 100)
Hysterectomy 11 0 (0) 11 (100) 0 (0) 0 (0) NA 100 (71.5–100) NA 100 (71.5–100)
Hip prosthesis 196 2 (1.0) 191 (97.5) 0 (0) 3 (1.5) 100 (15.8–100) 98.5 (95.5–99.7) 40.0 (5.3 – 85.3) 100 (98.1–100)
Knee prosthesis 130 3 (2.3) 127 (97.7) 0 (0) 0 (0) 100 (29.2–100) 100 (97.1–100) 100 (29.2–100) 100 (97.1–100)
Laminectomy 15 0 (0) 15 (100) 0 (0) 0 (0) NA 100 (78.2–100) NA 100 (78.2–100)
Cardiac surgery 26 1 (3.9) 25 (96.2) 0 (0) 0 (0) 100 (2.5–100) 100 (86.3–100) 100 (2.5–100) 100 (86.3–100)
NOTE. PPV, positive predictive value; NPV, negative predictive value. NA, not applicable.
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status (ie, SSI present as compared to absent) and the quality of
supervision by a medical supervisor, but not with total validation
scores, hospital size, private hospital status, number of operations
followed, training of the medical supervisor, full-time equivalents
dedicated for surveillance or understafﬁng. Misclassiﬁcation of
the type of infection (ie, superﬁcial incisional, deep incisional
infection, or organ/space infection) was independently associated
with lower adequacy of documentation.
Taken together, our ﬁndings highlight the importance of high-
quality data for interfacility comparisons and, more importantly,
public reporting of healthcare-associated surveillance data.
Interpretive variation despite uniform surveillance deﬁnitions has
been shown previously.26,27 Furthermore, public reporting of
HAI surveillance data in a system where there is great disincentive
to have unfavorable outcome data may result in exclusion or
reclassiﬁcation of events as opposed to preventing actual negative
outcomes.28 Therefore, apart from a standardized methodology,
validation of surveillance data, surveillance methods, and
operations within participating facilities by an independent party
are key for quality assurance under such circumstances.
As mentioned previously, the best means to validate a SSI
surveillance module is still unknown. Therefore, various
approaches have been proposed in the scientiﬁc literature or are
available together with the surveillance methodologies, such as
the validation toolkits provided by the NHSN.29 The methods
applied to validate surgical site infection surveillance (SSIS) in
The Netherlands have been published in 2007 byMannien et al.30
Thereby, process validation by means of a structured interview as
well as a prevalence study were performed. Overall positive pre-
dictive values and negative predictive values were then calculated.
Similarly, validation of SSIS data was performed in Scotland
by McCoubrey et al.12 Validation in terms of structure (ie,
trained personnel and systems for SSIS, systems to ensure
complete inclusion, check and conﬁrm the number of
operations) and in terms of process (ie, phone interview for
identiﬁcation of the systems for SSIS data collection and man-
agement at a local level) were performed. Outcome validation
was conducted by calculating sensitivity, speciﬁcity, positive
predictive value, and negative predictive value of the last 15 cases
of SSI and 60 further randomly selected cases.
Gastmeier et al10 compared 2 validation methods in a
prevalence survey (Nosokomiale Infektionen in Deutschland
Erfassung und Prävention, NIDEP) on nosocomial infections.10
On one hand, as in other previous studies,11,31–33 bedside vali-
dation of the 4 physician investigators was performed using 2
supervisors as the gold standard, and sensitivity and speciﬁcity
were calculated. In addition, the investigators were validated
using case studies.33
However, limitations of these approaches—including ours—
are that, ﬁrst, it remains unclear how and whether results of
validation of structure and process by structured interviews
translate to the validity of infection outcomes. Second, validation
by case studies allows for the assessment of knowledge among the
persons performing surveillance, but the conclusion from case
study results on SSIS performance is inappropriate with regard to
potential conﬂicts of interest because people may behave differ-
ently in the setting of case studies as compared to real-life situa-
tions in their own hospital. Third, there is no consensus about the
sensitivity required to consider surveillance results to be valid.
And last, given the low prevalence of SSI, large numbers of patient
charts need to be reviewed to achieve an adequate level of
precision.25,34
In conclusion, validation of process and structure of SSI
surveillance and of outcome data helps identify areas for
table 5. Characteristics of 483 Randomly Selected Cases With Originally Reported Infection at the Main Surgical Site and Complete
Documentation and Follow-Up Reviewed Between October 1, 2012, and June 26, 2016
Originally Reported Infections Validation
Variable Total
Superﬁcial
Incisional,
No. (%)
Deep
Incisional,
No. (%)
Organ-
Space,
No. (%)
Superﬁcial
Incisional,
No. (%)
Deep
Incisional,
No. (%)
Organ-
Space,
No. (%)
False
Positive,
No. (%)
Misclassiﬁcation of
Type of Infection,
No. (%)
All surgeries 483 205 (42.4) 79 (16.4) 199 (41.2) 204 (42.2) 52 (10.8) 226 (46.8) 1 (0.2) 46 (9.5)
Appendectomy 37 11 (29.7) 6 (16.2) 20 (54.1) 11 (29.7) 5 (13.5) 21 (56.8) 0 (0) 1 (2.7)
Colon surgery 213 79 (37.1) 32 (15.0) 102 (47.9) 79 (37.1) 22 (10.3) 112 (52.6) 0 (0) 20 (9.4)
Rectal surgery 5 2 (40.0) 2 (40.0) 1 (20.0) 1 (20.0) 2 (40.0) 2 (40.0) 0 (0) 2 (40.0)
Cholecystectomy 44 21 (47.7) 5 (11.4) 18 (40.9) 22 (50.0) 4 (9.1) 18 (40.9) 0 (0) 1 (2.3)
Herniorrhaphy 21 14 (66.7) 6 (28.6) 1 (4.8) 15 (71.4) 5 (23.8) 1 (4.8) 0 (0) 1 (4.8)
Gastric bypass
surgery
5 2 (40.0) 1 (20.0) 2 (40.0) 2 (40.0) 1 (20.0) 2 (40.0) 0 (0) 0 (0.0)
Caesarian
section
52 41 (78.9) 5 (9.6) 6 (11.5) 41 (78.9) 5 (9.6) 6 (11.5) 0 (0) 0 (0.0)
Hysterectomy 0 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Hip prostheses 66 18 (27.3) 15 (22.7) 33 (50.0) 17 (25.8) 4 (6.1) 44 (67.7) 1 (1.5) 14 (21.2)
Knee prostheses 33 13 (39.4) 6 (18.2) 14 (42.4) 13 (39.4) 2 (6.1) 18 (54.6) 0 (0) 6 (18.2)
Laminectomiy 1 0 (0) 0 (0) 1 (100) 1 0 (0) 0 (0) 0 (0) 0 (0)
Cardiac surgery 6 4 (66.7) 1 (33.3) 1 (33.3) 3 (50.0) 2 (33.3) 1 (16.7) 0 (0) 1 (16.7)
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improvement and estimate the proportion of underreporting
of SSI. Validation results are reported openly together with SSI
rates in Switzerland to help the public appraise the results of
SSI rates in individual hospitals. However, the efforts and cost
of validation are substantial; therefore, more sensitive and
efﬁcient methods for the detection of false-negative outcome
measures are urgently needed. Future research should focus on
the association between poor performance in process and
structure measurement and reported SSI rates.
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